News & Updates

Digital gut-directed hypnotherapy (GDH) programme reduces abdominal pain in adults with irritable bowel syndrome (IBS) compared with digital muscle relaxation (MR), according to a study presented at DDW 2023.

More severe faecal incontinence symptoms appear to burden tobacco smokers, reveals a recent study presented at DDW 2023. Tobacco use is also associated with weaker anal sphincter tone and increased rectal hypersensitivity on high-resolution anorectal manometry (HRAM).

Use of dexmedetomidine has lessened the effective concentration (EC50) of propofol administered via plasma target-controlled infusion (TCI) during gastrointestinal endoscopy, a study has found. A 0.5‒1 μg/kg dose of dexmedetomidine results in a lower heart rate (HR) without bradycardia.

Induction therapy with guselkumab, an interleukin-23 p19 subunit antagonist, results in clinical and symptomatic remission, as well as other endoscopic improvements in patients with moderate-to-severe active ulcerative colitis (UC), according to the QUASAR study presented at DDW 2023.

Histologic remission using the validated Nancy histologic index (NHI) score is independently associated with a significantly longer relapse-free survival and appears to be a better therapeutic target than endoscopic remission in patients with ulcerative colitis (UC), reports a study.

A retrospective study in Hong Kong has shown that stereotactic body radiotherapy (SBRT) is an effective and well-tolerated treatment for patients with unresectable liver metastases.

Helicobacter pylori eradication therapy not only resulted in transient alteration of gut microbiota, but also significantly altered the gut virome, researchers from the University of Hong Kong (HKU) have found.

Initial treatment with over-the-scope clips (OTSCs) appears superior to standard endoscopic treatment in reducing the risk for further bleeding from nonvariceal upper gastrointestinal causes that are responsive to OTSC placement, results of a study have shown.